Syrs stocktwits
Syros is a stew of talent directed at significantly improving outcomes for patients with challenging diseases. I want to be a part of that – to contribute to success for Syros and for patients who need better alternatives.” - Charlie, VP of New Product Planning Cronos Group Inc. CRON 8.05 1.45 (21.89%). NASDAQ Updated Jun 8, 2020 11:59 PM Amarin Corporation plc. AMRN 7.32 0.64 (9.57%). NASDAQ Updated Jun 8, 2020 8:01 PM The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was founded in 2011 and is headquartered in Cambridge, Massachusetts. Description: Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology and other related markets that address gene control and cancer. Syros Pharmaceuticals (SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will present new preclinical data on the anti-tumor activity of SY-5609, its highly selective and potent oral cyclin-dependent kinase 7 inhibitor, in models of colorectal cancer. Find the latest ObsEva SA (OBSV) stock quote, history, news and other vital information to help you with your stock trading and investing.
ARKK Ratings, Holdings, Quotes, and More | ETF Daily News
MannKind (NASDAQ: MNKD) disclosed an amendment to its facility agreement with DeerfieldFrom the filing:On September 5, 2018, MannKind Corporation (the Company) and MannKind LLC, the Stockpile - Your Favorite Stocks By The Dollar
Westwater Resources Inc. - MarketWatch
Death Cross detected for SYRS (Syros Pharmaceutical) at the close price of 4.75. Trading at a 1 % level between the 52week High (11.93) and 52week Low (4.70). The average analyst 1-year target price is 14.0 with an average buy and a score of 1.9. Death Cross 7 % SYRS 4.75 Syros Pharmaceutical HiLo 0.7 […] Ideanomics Stock Forecast: down to 53686.10 USD? - SSC ...
Syros Pharmaceuticals (SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will present new preclinical data on the anti-tumor activity of SY-5609, its highly selective and potent oral cyclin-dependent kinase 7 inhibitor, in models of colorectal cancer.
Biotech Stocks List - Full List of Healthcare Companies The Coronavirus is spreading quickly. Italy is the biggest European country that is currently battling over 1000 cases in February. The first death in the US happened 2/29/2020 on a Saturday.
28 Aug 2019 Sina Weibo SiteJot Skype Slashdot SMS StockTwits Svejo Symbaloo Bookmarks Threema Trello Tuenti Twiddla TypePad Post Viadeo Viber
Find the latest FuelCell Energy, Inc. (FCEL) stock quote, history, news and other vital information to help you with your stock trading and investing. GNC | Complete GNC Holdings Inc. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Real-time trade and investing ideas on Syros Pharmaceuticals SYRS from the largest community of traders and investors.